• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

测量和计算核医学患者附近剂量率的比较。

Comparison of measured and calculated dose rates near nuclear medicine patients.

机构信息

Institute of Radiation Medicine, Fudan University, No. 2094, Xietu Road, Shanghai, 200032, PR China.

出版信息

Health Phys. 2013 Aug;105(2):187-91. doi: 10.1097/HP.0b013e318290cc0e.

DOI:10.1097/HP.0b013e318290cc0e
PMID:23799503
Abstract

Widely used release criteria for patients receiving radiopharmaceuticals (NUREG-1556, Vol. 9, Rev.1, Appendix U) are known to be overly conservative. The authors measured external exposure rates near patients treated with I, Tc, and F and compared the measurements to calculated values using point and line source models. The external exposure dose rates for 231, 11, and 52 patients scanned or treated with I, Tc, and F, respectively, were measured at 0.3 m and 1.0 m shortly after radiopharmaceutical administration. Calculated values were always higher than measured values and suggested the application of "self-shielding factors," as suggested by Siegel et al. in 2002. The self-shielding factors of point and line source models for I at 1 m were 0.60 ± 0.16 and 0.73 ± 0.20, respectively. For Tc patients, the self-shielding factors for point and line source models were 0.44 ± 0.19 and 0.55 ± 0.23, and the values were 0.50 ± 0.09 and 0.60 ± 0.12, respectively, for F (all FDG) patients. Treating patients as unshielded point sources of radiation is clearly inappropriate. In reality, they are volume sources, but treatment of their exposures using a line source model with appropriate self-shielding factors produces a more realistic, but still conservative, approach for managing patient release.

摘要

广泛应用于接受放射性药物治疗的患者的释放标准(NUREG-1556,第 9 卷,修订版 1,附录 U)被认为过于保守。作者测量了接受 I、Tc 和 F 治疗的患者附近的体外照射率,并将测量值与使用点源和线源模型计算的值进行了比较。分别对 231、11 和 52 名接受 I、Tc 和 F 扫描或治疗的患者,在放射性药物给药后不久,在 0.3m 和 1.0m 处测量了体外照射剂量率。计算值始终高于测量值,并提示应用 Siegel 等人于 2002 年提出的“自屏蔽因子”。在 1m 处,I 的点源和线源模型的自屏蔽因子分别为 0.60±0.16 和 0.73±0.20。对于 Tc 患者,点源和线源模型的自屏蔽因子分别为 0.44±0.19 和 0.55±0.23,对于所有 FDG 患者,自屏蔽因子分别为 0.50±0.09 和 0.60±0.12。将患者视为无屏蔽的放射源显然是不合适的。实际上,他们是体积源,但使用具有适当自屏蔽因子的线源模型来处理他们的暴露,可以为管理患者释放提供一种更现实但仍然保守的方法。

相似文献

1
Comparison of measured and calculated dose rates near nuclear medicine patients.测量和计算核医学患者附近剂量率的比较。
Health Phys. 2013 Aug;105(2):187-91. doi: 10.1097/HP.0b013e318290cc0e.
2
Correction factors for more accurate estimates of exposure rates near radioactive patients: experimental, point, and line source models.用于更准确估计放射性患者附近暴露率的校正因子:实验、点源和线源模型。
Health Phys. 2007 Dec;93(6):678-88. doi: 10.1097/01.HP.0000275298.69543.5c.
3
Comparing dose rates near a radioactive patient evaluated using various source models: point, line, cylinder, and anthropomorphic phantoms.比较使用各种源模型评估的放射性患者附近的剂量率:点源、线源、柱体源和人体模型。
Health Phys. 2015 Jul;109(1):69-77. doi: 10.1097/HP.0000000000000294.
4
Comparison of point, line and volume dose calculations for exposure to nuclear medicine therapy patients.比较核医学治疗患者暴露的点、线和体积剂量计算。
Health Phys. 2011 Feb;100(2):185-90. doi: 10.1097/HP.0b013e3181eacf38.
5
A new proposal for monitoring patients in nuclear medicine.核医学中监测患者的一项新提议。
Health Phys. 2006 Dec;91(6):624-9. doi: 10.1097/01.HP.0000225467.10064.34.
6
Assessment of the Point-Source Method for Estimating Dose Rates to Members of the Public from Exposure to Patients with 131I Thyroid Treatment.评估点源法用于估算公众因接触接受¹³¹I甲状腺治疗患者而受到的剂量率。
Health Phys. 2015 Sep;109(3):233-41. doi: 10.1097/HP.0000000000000327.
7
Licensee over-reliance on conservatisms in NRC guidance regarding the release of patients treated with 131I.被许可方过度依赖美国核管理委员会(NRC)关于接受131I治疗患者出院指导中的保守做法。
Health Phys. 2007 Dec;93(6):667-77. doi: 10.1097/01.HP.0000270300.34270.44.
8
Hand exposure of nuclear medicine workers during administration of radioiodine.放射性碘给药过程中核医学工作者的手部暴露。
Radiat Prot Dosimetry. 2012 Aug;151(1):147-52. doi: 10.1093/rpd/ncr447. Epub 2011 Dec 5.
9
Patient release criteria for low dose rate brachytherapy implants.低剂量率近距离放射治疗植入物的患者释放标准。
Health Phys. 2013 Apr;104(4):413-8. doi: 10.1097/HP.0b013e31828016b7.
10
Hospital discharge of patients with thyroid carcinoma treated with 131I.接受¹³¹I治疗的甲状腺癌患者出院情况。
J Nucl Med. 2002 Jan;43(1):61-5.

引用本文的文献

1
Radiation safety measures in diagnostic nuclear medicine, based on the potential radiation dose emitted by radioactive patients.基于放射性患者所发射的潜在辐射剂量的诊断核医学中的辐射安全措施。
Radiol Bras. 2023 Jan-Feb;56(1):13-20. doi: 10.1590/0100-3984.2022.0064.
2
SUBSTANTIAL EXTERNAL DOSE RATE VARIABILITY OBSERVED IN A COHORT OF LU-177 PATIENTS INDEPENDENT OF BMI AND SEX.在一组与 BMI 和性别无关的 Lu-177 患者中观察到实质性的外剂量率变化。
Radiat Prot Dosimetry. 2022 Oct 16;198(19):1476-1482. doi: 10.1093/rpd/ncac187.
3
Radiation Protection and Occupational Exposure on Ga-PSMA-11-Based Cerenkov Luminescence Imaging Procedures in Robot-Assisted Prostatectomy.
机器人辅助前列腺切除术基于 Ga-PSMA-11 的 Cerenkov 发光成像程序中的辐射防护和职业照射。
J Nucl Med. 2022 Sep;63(9):1349-1356. doi: 10.2967/jnumed.121.263175. Epub 2021 Dec 16.